Sichuan Kelun Pharmaceutical Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Sichuan Liu

Chief Executive Officer (CEO)

CN¥4.8m

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	15yrs
Participación del CEO	0.5%
Permanencia media de la dirección	3.2yrs
Promedio de permanencia en la Junta Directiva	8.4yrs

Actualizaciones recientes de la dirección

Recent updates

CEO

Sichuan Liu (40 yo)

15yrs

Permanencia

CN¥4,800,000

Compensación

Mr. Sichuan Liu has been a Director of Sichuan Kelun Pharmaceutical Co., Ltd. since June 26, 2009 and serves as its General Manager. He is a Non-Executive Director of Sichuan Kelun-Biotech Biopharmaceutica...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Sichuan Liu	GM & Director	no data	CN¥4.80m	0.52% CN¥ 266.2m
Degui Lai	CFO & Deputy GM	9.7yrs	CN¥3.00m	0.033% CN¥ 16.8m
Hao Feng	Deputy GM & Secretary of the Board of Directors	10.2yrs	CN¥3.00m	0.032% CN¥ 16.3m
Nanchao Ding	Deputy General Manager	4.2yrs	CN¥2.40m	sin datos
Wendi Fan	Deputy General Manager	2.2yrs	CN¥2.33m	0.0094% CN¥ 4.8m
Yihong Liao	Deputy General Manager	2.2yrs	CN¥1.65m	0.0076% CN¥ 3.9m
Liang Wang	Deputy General Manager	2.2yrs	CN¥900.00k	0.0031% CN¥ 1.6m
Deguang Chen	Officer	no data	CN¥700.00k	sin datos

3.2yrs

Permanencia media

45yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 002422 se considera experimentado (3 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Sichuan Liu	GM & Director	15yrs	CN¥4.80m	0.52% CN¥ 266.2m
Genxin Liu	Chairman of the Board of Directors	no data	CN¥2.00m	23.83% CN¥ 12.1b
Guosheng He	Non Independent Director	5.2yrs	CN¥100.00k	sin datos
Changyan Zheng	Employee-Representative Member of the Board of Supervisors	16.1yrs	sin datos	0.0039% CN¥ 2.0m
Yunpei Guo	Member of the Board of Supervisors	8.4yrs	sin datos	sin datos
Jinbo Gao	Independent Director	3yrs	CN¥100.00k	sin datos
Guangji Wang	Non Independent Director	10.1yrs	CN¥100.00k	sin datos
Wan Peng	Chairman of Board of Supervisors	9.3yrs	sin datos	0.00063% CN¥ 319.6k
Shichi Ren	Independent Director	3yrs	CN¥100.00k	sin datos
Minggang Ou	Independent Director	1.8yrs	sin datos	sin datos

8.4yrs

Permanencia media

56.5yo

Promedio de edad

Junta con experiencia: La junta directiva de 002422 se considera experimentada (8.3 años de antigüedad promedio).

Sichuan Kelun Pharmaceutical Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

High number of new directors

High number of new directors

High number of new directors

Sichuan Kelun Pharmaceutical Co., Ltd., Annual General Meeting, May 05, 2022

Recent updates

Sichuan Kelun Pharmaceutical Co., Ltd. Announces 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 29 May 2024

Sichuan Kelun Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2023

First quarter 2024 earnings released: EPS: CN¥0.67 (vs CN¥0.57 in 1Q 2023)

Full year 2023 earnings released: EPS: CN¥1.69 (vs CN¥1.22 in FY 2022)

Sichuan Kelun Pharmaceutical Co., Ltd. to Report Q1, 2024 Results on Apr 25, 2024

Investor sentiment improves as stock rises 15%

Sichuan Kelun Pharmaceutical Co., Ltd. to Report Fiscal Year 2023 Results on Apr 25, 2024

Third quarter 2023 earnings released: EPS: CN¥0.38 (vs CN¥0.38 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.41 (vs CN¥0.43 in 2Q 2022)

Sichuan Kelun Pharmaceutical Co., Ltd. Announces Cash Dividend on Share A for 2022, Payable on May 15, 2023

Sichuan Kelun Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2022

Full year 2022 earnings released: EPS: CN¥1.22 (vs CN¥0.78 in FY 2021)

Investor sentiment improved over the past week

High number of new directors

Third quarter 2022 earnings released: EPS: CN¥0.38 (vs CN¥0.25 in 3Q 2021)

Investor sentiment improved over the past week

High number of new directors

Second quarter 2022 earnings released: EPS: CN¥0.43 (vs CN¥0.23 in 2Q 2021)

Sichuan Kelun Pharmaceutical Co., Ltd. Announces Final Distribution for the Year 2021, Payable on 16 May 2022

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS: CN¥0.20 (vs CN¥0.12 in 1Q 2021)

Sichuan Kelun Pharmaceutical Co., Ltd. (SZSE:002422) announces an Equity Buyback for CNY 200 million worth of its shares.

High number of new directors

Sichuan Kelun Pharmaceutical Co., Ltd., Annual General Meeting, May 05, 2022

Sichuan Kelun Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2021

Full year 2021 earnings released: EPS: CN¥0.78 (vs CN¥0.58 in FY 2020)

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Third quarter 2021 earnings released: EPS CN¥0.25 (vs CN¥0.21 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.23 (vs CN¥0.10 in 2Q 2020)

Sichuan Kelun Pharmaceutical Co., Ltd. announced that it expects to receive CNY 3 billion in funding

Sichuan Kelun Pharmaceutical Co., Ltd. Proposes Final Dividend for the Year 2020

Full year 2020 earnings released: EPS CN¥0.58 (vs CN¥0.66 in FY 2019)

Investor sentiment improved over the past week

New 90-day high: CN¥21.88

New 90-day low: CN¥18.06

New 90-day low: CN¥20.47

New 90-day low: CN¥21.62

Revenue misses expectations

Third quarter earnings released

Sichuan Kelun Pharmaceutical Co., Ltd. (Kelun) entered into an agreement to acquire Shanghai Century Acquisition Corporation (Amex: SHA) in a reverse merger transaction.

First half earnings released

New 90-day high - CN¥25.76

Sichuan Kelun Pharmaceutical Co., Ltd. to Report First Half, 2020 Results on Aug 31, 2020

New 90-day high - CN¥23.83

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad